Daily Management and Long-Term Wellness
At a Glance
Daily CAD care focuses on avoiding cold, keeping blood samples and transfusions appropriately warm, and checking blood tests such as hemoglobin, LDH, and bilirubin. Regular hematology follow-up helps detect red-cell breakdown, clot risk, and treatment-related changes early.
Living with Cold Agglutinin Disease (CAD) means becoming an expert in your own environment and a proactive advocate for your safety. Because your immune system reacts to drops in temperature, day-to-day management is about more than just “wearing a coat”—it is about building a lifestyle that protects your blood cells from the cold [1][2].
Master the Art of Cold Avoidance
Cold avoidance is the foundation of CAD care. For many with mild disease, these lifestyle adjustments are the primary way they stay healthy [2]. However, this should support sensible protection without creating excessive fear or unnecessary restriction.
- Target the Extremities: Your nose, ears, fingers, and toes are the most vulnerable to cooling. Wear thermal socks, insulated gloves, and a scarf that can cover your face when appropriate [3][4].
- The Layering Strategy: Use multiple layers of clothing rather than one heavy item. This allows you to adjust quickly when moving between different environments, such as a cold car and a heated building [3].
- Beware of “Invisible” Cold: Air-conditioned grocery stores, drafts, and handling frozen foods can trigger a reaction [3]. Keep a “CAD kit” in your car that includes a warm sweater and gloves, regardless of the season.
- Hydration: During a hemolytic crisis, maintaining normal or clinician-recommended fluid intake is advised, but hydration does not stop immune destruction and must respect heart or kidney fluid restrictions. Dark urine or weakness requires medical assessment, though fluids support kidney function [5].
Critical Safety: Lab Work and Transfusions
Two of the most important safety rules for CAD involve medical procedures:
- Warmed Blood Samples: For specific tests like cold-agglutinin titers or when clumping interferes with cell counts, if your blood is drawn for testing, it should be kept at body temperature (37°C) until it is processed [6]. If the sample cools, the results for your red blood cell count may be “artifactually” low, meaning the machine sees clumps instead of individual cells [7].
- Warmed Transfusions: If you ever require a blood transfusion, the red cells ideally should be warmed using an approved in-line blood warmer [8][9]. Infusing cold blood into a CAD patient can potentially cause a hemolytic reaction where your body destroys the donor blood [10][5]. However, in a life-threatening emergency, urgent transfusion decisions must be made by the treating team; never delay or refuse life-saving emergency care while trying to enforce this [8][9].
Long-Term Monitoring and Surveillance
Even when you feel well, your “hemolysis markers” should be checked regularly. This helps you and your doctor understand your baseline and catch flares early [11].
- Stable Monitoring: Typically includes a Complete Blood Count (CBC) to check hemoglobin, along with LDH and bilirubin to measure active cell destruction [12][13].
- Complement Inhibitor Monitoring: If you are taking a drug like sutimlimab, your doctor may monitor C4 levels [14]. A drop in C4 or a rise in bilirubin can be one signal of “breakthrough hemolysis,” alongside your symptoms and hemoglobin, often triggered by a recent infection [15][16].
- Clot Protection: Because CAD patients have an increased risk of blood clots compared to the general population, your doctor may discuss thrombosis prophylaxis (blood thinners) [17]. However, never start an anticoagulant on your own; this is highly individualized based on bleeding risk and other factors [17][1].
The Psychological Toll of CAD
Living with a rare condition that few people understand can be exhausting. The chronic fatigue of CAD is not just physical; it can lead to “fatigue of the spirit,” where the constant vigilance required to stay warm feels burdensome [3][18].
Many patients find that connecting with a CAD-specific support group reduces the isolation of the diagnosis. Validating that your fatigue is real—and that it is caused by a biological process—is a crucial part of your long-term well-being. Using a clinician-completed CAD Medical-Alert Card containing your diagnosis, transfusion guidance, and hematology contact can also provide practical reassurance.
Common questions in this guide
How can I avoid cold-related problems with CAD every day?
Why do CAD blood samples need special handling?
What precautions are needed if I need a blood transfusion with CAD?
How is cold agglutinin disease monitored over time?
What signs might mean my CAD is flaring?
Should everyone with CAD take a blood thinner to prevent clots?
How can I protect my long-term well-being while living with CAD?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Cold agglutinin disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are my specific 'stable' lab values, and how often should we check my hemoglobin, LDH, and bilirubin to catch a flare early?
- 2.Can you help me complete a 'CAD Medical-Alert Card' that explains the need for appropriate warming and transfusion guidance?
- 3.Given my individual history, bleeding risk, and the high risk of blood clots in CAD, do you recommend any thrombosis prophylaxis?
- 4.If I am on a complement inhibitor like sutimlimab, what symptoms of 'breakthrough hemolysis' should prompt me to contact you?
- 5.How should we adjust my monitoring or treatment if I need to have a surgery or a medical procedure?
References
References (18)
- 1
[Cold agglutinin disease (CAD)].
Röth A, Borchert K, Dorn C, et al.
Innere Medizin (Heidelberg, Germany) 2025; (66(9)):986-996 doi:10.1007/s00108-025-01926-0.
PMID: 40691722 - 2
How I manage patients with cold agglutinin disease.
Berentsen S
British journal of haematology 2018; (181(3)):320-330 doi:10.1111/bjh.15109.
PMID: 29363757 - 3
Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD-SIQ).
Joly F, DasMahapatra P, DiBenedetti DB, et al.
European journal of haematology 2023; (111(2)):211-219 doi:10.1111/ejh.13984.
PMID: 37128840 - 4
Multifocal thrombosis with peripheral gangrene in a young boy: Mycoplasma infection triggered cold agglutinin disease.
Sudhakar M, Mohandoss V, Chaudhary H, et al.
Immunobiology 2021; (226(3)):152075 doi:10.1016/j.imbio.2021.152075.
PMID: 33711641 - 5
A case of autoimmune hemolytic anemia with cold agglutinin disease post-operation for recurrent ovarian cancer.
Sugimoto A, Yamada H, Tasaki K, et al.
International cancer conference journal 2025; (14(3)):235-240 doi:10.1007/s13691-025-00758-x.
PMID: 40625772 - 6
A Rare Non-Hemolytic Case of Idiopathic Cold Agglutinin Disease.
Erkus E, Kocak MZ, Aktas G, et al.
Clinical laboratory 2018; (64(6)):1075-1078 doi:10.7754/Clin.Lab.2018.180114.
PMID: 29945320 - 7
Unusual underlying disorder for pulmonary embolism: Cold agglutinin disease.
Onishi S, Ichiba T, Miyoshi N, et al.
Journal of cardiology cases 2017; (15(2)):43-45 doi:10.1016/j.jccase.2016.10.005.
PMID: 30546693 - 8
Ambulatory total knee arthroplasty in a patient with cold agglutinin disease.
Bansal S
Canadian journal of anaesthesia = Journal canadien d'anesthesie 2025; (72(6)):1015-1020 doi:10.1007/s12630-025-02961-z.
PMID: 40346430 - 9
A Rare Case of Severe Hemolytic Anemia and Pulmonary Embolism Secondary to Mycoplasma pneumoniae Infection.
Kumaravel Kanagavelu AS, Nagumantry SK, Sagi SV, Oyibo SO
Journal of medical cases 2022; (13(3)):119-124 doi:10.14740/jmc3866.
PMID: 35356396 - 10
IgA plasma cell myeloma presenting as cold agglutinin-induced haemolytic transfusion reaction.
Mehdipour Dalivand M, Woddor N, Makuria A, et al.
BMJ case reports 2024; (17(2)) doi:10.1136/bcr-2022-251638.
PMID: 38423573 - 11
Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
Röth A, Fryzek J, Jiang X, et al.
Transfusion 2022; (62(1)):51-59 doi:10.1111/trf.16745.
PMID: 34813663 - 12
Cold Agglutinin-Mediated Hemolytic Anemia Preceding the Diagnosis of Acute Myeloid Leukemia: A Case Report and Literature Review.
Tariq MA, Almahmood M, Mushtaq J, Incorvati J
Cureus 2026; (18(4)):e106577 doi:10.7759/cureus.106577.
PMID: 42110104 - 13
Refractory cold autoimmune hemolytic anemia as initial presentation of gastric B cell lymphoma: a case report.
Fernando G, Samarasingha SAPN, Karunatilake H, et al.
Journal of medical case reports 2025; (19(1)):487 doi:10.1186/s13256-025-05519-1.
PMID: 41063194 - 14
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
Röth A, Berentsen S, Barcellini W, et al.
Blood 2022; (140(9)):980-991 doi:10.1182/blood.2021014955.
PMID: 35687757 - 15
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.
Fattizzo B, Sambruna E, Miyakawa Y, et al.
American journal of hematology 2026; (101(7)):1597-1604 doi:10.1002/ajh.70307.
PMID: 41991255 - 16
Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.
Gelbenegger G, Schoergenhofer C, Derhaschnig U, et al.
Blood advances 2020; (4(6)):997-1005 doi:10.1182/bloodadvances.2019001321.
PMID: 32176765 - 17
Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis.
Broome CM, Cunningham JM, Mullins M, et al.
Research and practice in thrombosis and haemostasis 2020; (4(4)):628-635 doi:10.1002/rth2.12333.
PMID: 32548562 - 18
The Burden of Cold Agglutinin Disease on Patients' Daily Life: Web-Based Cross-sectional Survey of 50 American Patients.
Joly F, Schmitt LA, Watson PAM, et al.
JMIR formative research 2022; (6(7)):e34248 doi:10.2196/34248.
PMID: 35867390
This page provides general information about living with cold agglutinin disease and does not constitute medical advice. Your hematology team should personalize cold protection, monitoring, medicines, and transfusion planning, especially during an emergency.